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Treating Viral Respiratory Tract Infections with Antibiotics in Hospitals:
No Longer a Case of Mistaken Identity
Abstract
Widespread use of antibiotics in hospitalized patients contributes to the development of multidrug resistant
organisms that make many infections increasingly difficult to treat. Despite calls to prescribe antibiotics
judiciously, many physicians continue to order antibiotics for inpatients who do not need them. This Issue
Brief investigates antibiotic use in hospitalized adults with a confirmed viral infection, a group of patients that
may not benefit from such therapy. Understanding the factors that lead to inappropriate antibiotic use may
help change clinical practice and limit antibiotic resistance.
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Editor’s note: Widespread use of antibiotics in hospitalized patients 
contributes to the development of multidrug resistant organisms that make 
many infections increasingly difficult to treat. Despite calls to prescribe 
antibiotics judiciously, many physicians continue to order antibiotics for 
inpatients who do not need them. This Issue Brief investigates antibiotic use 
in hospitalized adults with a confirmed viral infection, a group of patients 
that may not benefit from such therapy. Understanding the factors that lead 
to inappropriate antibiotic use may help change clinical practice and limit 
antibiotic resistance.
Widespread antibiotic use in the treatment of hospitalized patients 
promotes the development of antibiotic resistance. A recent study of U.S. 
teaching hospitals found that 63.5 % of patients discharged in 2006 had 
received at least one dose of an antibacterial drug. It is estimated that about 
30% of antibiotic-days for hospitalized adults are unnecessary. 
• One area where antibiotic use could be limited is in the treatment of 
patients with viral respiratory tract infections (RTIs). Patients who 
present with acute respiratory symptoms are often prescribed antibiotics 
on admission before it is clear whether their illness is viral or bacterial in 
origin. Antibiotics are not effective in treating viral infections.
• Recently, highly accurate tests have been developed to identify several 
respiratory infections, including influenza A and B, parainfluenza, 
adenovirus, and respiratory syncytial virus (RSV). These tests now make 
it possible for clinicians to confirm viral causes for illnesses that might 
otherwise be mistaken for bacterial infections. 
• Despite this theoretical advantage, it is unclear whether improved 
diagnosis of viral RTIs has actually led to reduced antibiotic use in 
hospitalized adults.
Most patients in teaching 
hospitals receive at least 
one dose of antibiotics
Study investigates 
antibiotic use in hospitalized 
patients with viral
respiratory infections
Many patients were 
prescribed antibiotics on 
admission, and almost all 
stayed on antibiotics after 
a viral respiratory tract 
infection was confirmed
The analysis revealed that antibiotic use in patients with confirmed viral 
RTI was common. The decision to stop antibiotic therapy was rare. 
Radiographic evidence that caused concern about pneumonia was the 
strongest predictor of continued antibiotic use. 
• Of the 196 patients, 131 (67%) began antibiotic therapy, and 125 
(64%) continued to receive antibiotics after the diagnosis of viral RTI. 
The average time from admission to viral RTI diagnosis was one day. 
For patients given antibiotics, the median duration of antibiotic use 
was 8 days.
• The only anti-viral drug used, oseltamivar, was prescribed for a small 
percentage (21%) of patients with influenza; half of these patients 
continued to receive antibiotics in addition.
• Forty-six (37%) of the 125 patients who continued to receive 
antibiotics had abnormal chest radiographs on admission. 
Concern about concomitant bacterial pneumonia in these patients 
might prompt clinicians to continue antibiotic therapy. After adjusting 
for other possible factors, patients with abnormal chest imaging on 
admission were four times as likely to use antibiotics as those with 
negative chest imaging. 
• However, the majority of patients who were prescribed antibiotics had 
normal radiographs. Possible factors that might have led clinicians to 
use antibiotics, such as patient age, presenting signs, symptoms, and 
comorbid conditions, were not associated with continuation. 
The reasons for continuing antibiotic treatment in these patients were 
not apparent.
The investigators conducted a retrospective analysis of antibiotic use among 
newly hospitalized patients admitted with acute respiratory symptoms who 
subsequently received a diagnosis of viral RTI. 
• All patients were admitted to one of two hospitals affiliated with the 
University of Pennsylvania Health System between November 1, 2005 
and August 1, 2007. Patients with confirmed viral RTI were identified 
through the records of the lab that performs viral diagnostics for the 
health system.
• Hospital medical records were reviewed to exclude patients with a 
documented bacterial infection within or outside the respiratory tract. 
Antibiotic use was ascertained from the hospitals’ electronic medication 
ordering system.
• The study included 196 patients with viral RTI. More than 70% of 
them had influenza, 15% had RSV, 7% had adenovirus, and 6% had a 
parainfluenza virus.
Continued on next page.
POLICY IMPLICATIONS These data demonstrate at least one area where antibiotics are commonly 
used in hospitalized patients without clear reason. The study did not reveal 
any clinical benefit to continuing antibiotics once a viral RTI is confirmed. 
In some cases, it might have led to harm.
• The findings could be useful in targeting interventions to limit 
the use of unnecessary antibiotics among inpatients. An antibiotic 
stewardship program might be beneficial in targeting patients who 
receive a diagnosis of viral RTI. One approach might be a voluntary or 
mandatory antibiotic “time-out” in which the physician reassesses the 
need for antibiotics when the results are received.
• Although antibiotics may have been used to prevent a secondary 
bacterial infection, there are few data to support such practice. In 
contrast to antibiotic use, an effective antiviral treatment for influenza 
was used in a small minority of patients with confirmed influenza.
• Further research is needed to understand these clinical practice patterns. 
It is possible that physician anxiety over concurrent or developing 
bacterial infection is the reason. If so, then educational programs 
may help alleviate this concern and reduce overuse of antibiotics in 
hospitalized patients. 
Patients on antibiotics 
did not seem to benefit 
from this treatment
The study looked at a number of patient outcomes and complications in 
patients given antibiotics. Although the study was not designed to detect 
small differences in outcomes, the results indicate that the patients who 
continued on antibiotics fared no better than those who did not, and some 
might have been harmed by the treatment.
• Median length of hospital stay was 5 days for patients on antibiotics, 
compared with 3 days for patient not given antibiotics after receiving a 
diagnosis of viral RTI. In-hospital mortality was higher in the antibiotic 
continuation group (10 vs. 0 deaths). These findings do not suggest 
that antibiotics were the cause of the increased length of hospitalization 
or the cause of the higher death rate. Patients who were very sick 
might have been more likely to receive antibiotics in an overly cautious 
approach to their care. And because these patients were sicker, they were 
also more likely to have long hospitalizations and higher mortality.
• However, eight patients (6%) who continued antibiotic therapy 
developed diarrhea from C. difficile infection, compared to 
0 patients not on antibiotics. This is a well-established risk of antibiotic 
use. Here, the causal link between antibiotic use and complications is 
more plausible.
• Patients who continued on antibiotics were more likely to be 
rehospitalized within 30 days of discharge, although the study was too 
small to determine whether this result was simply due to chance.
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POLICY IMPLICATIONS
(cont’d)
• These data should bolster ongoing efforts to limit inappropriate 
antibiotic use. The Centers for Disease Control and Prevention 
has launched Get Smart for Healthcare, a new campaign focused on 
improving antibiotic use in inpatient healthcare settings through the 
implementation of antibiotic stewardship programs. These programs are 
interventions designed to ensure that hospitalized patients receive the 
right antibiotic at the right time.
